- Trials with a EudraCT protocol (9)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (0)
9 result(s) found for: Noonan Syndrome.
Displaying page 1 of 1.
EudraCT Number: 2018-000750-22 | Sponsor Protocol Number: GHLIQUID-4020 | Start Date*: 2018-04-12 | |||||||||||
Sponsor Name:Novo Nordisk A/S | |||||||||||||
Full Title: A trial investigating the long-term efficacy and safety of two doses of NN-220 (somatropin [genetical recombination]) in short stature due to Noonan syndrome | |||||||||||||
Medical condition: Noonan Syndrome | |||||||||||||
|
|||||||||||||
Population Age: Children, Under 18 | Gender: Male, Female | ||||||||||||
Trial protocol: Outside EU/EEA | |||||||||||||
Trial results: View results |
EudraCT Number: 2011-003392-10 | Sponsor Protocol Number: CMEK162Y2201 | Start Date*: 2012-01-23 | ||||||||||||||||
Sponsor Name:Novartis Pharma Services AG | ||||||||||||||||||
Full Title: An open label study to assess safety, tolerability, pharmacokinetics and pharmacodynamics of MEK162 in Noonan syndrome hypertrophic cardiomyopathy. | ||||||||||||||||||
Medical condition: Noonan syndrome hypertrophic cardiomyopathy | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults | Gender: Male, Female | |||||||||||||||||
Trial protocol: GB (GB - no longer in EU/EEA) | ||||||||||||||||||
Trial results: View results |
EudraCT Number: 2005-000042-37 | Sponsor Protocol Number: GHNOO-1658 | Start Date*: 2005-07-11 | |||||||||||
Sponsor Name:Novo Nordisk A/S | |||||||||||||
Full Title: Norditropin Treatment in Subjects with Noonan Syndrome. Effects on Linear Growth and Final Height - Data Collection and Follow-up Visit | |||||||||||||
Medical condition: Noonan syndrome associated short stature | |||||||||||||
|
|||||||||||||
Population Age: Adolescents, Under 18, Adults | Gender: Male, Female | ||||||||||||
Trial protocol: SE (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2016-005022-10 | Sponsor Protocol Number: SYN-1748-MAL-0030-I | Start Date*: 2018-02-13 | ||||||||||||||||
Sponsor Name:Technische Universität München, Fakultät für Medizin | ||||||||||||||||||
Full Title: Improvement of synaptic plasticity and cognitive function in RAS pathway disorders | ||||||||||||||||||
Medical condition: Noonan Syndrom and Neurofibromatosis Type 1 | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adolescents, Under 18, Adults, Elderly | Gender: Male, Female | |||||||||||||||||
Trial protocol: DE (Completed) | ||||||||||||||||||
Trial results: View results |
EudraCT Number: 2016-000647-14 | Sponsor Protocol Number: 15782601 | Start Date*: 2016-05-23 |
Sponsor Name:University Hospital Toulouse | ||
Full Title: Treatment with HMG-COA reductase inhibitor (simvastatin) of growth and bone abnormalities in children with Noonan syndrome : a phase III randomised, double-blind, placebo-controlled therapeutic trial | ||
Medical condition: Noonan syndrome | ||
Disease: | ||
Population Age: Children, Adolescents, Under 18 | Gender: Male, Female | |
Trial protocol: FR (Completed) | ||
Trial results: (No results available) |
EudraCT Number: 2021-005607-13 | Sponsor Protocol Number: NN8640-4467 | Start Date*: 2022-07-15 | ||||||||||||||||||||||||||
Sponsor Name:NOVO NORDISK. S.P.A. | ||||||||||||||||||||||||||||
Full Title: A study comparing the effect and safety of once weekly dosing of somapacitan with daily Norditropin® as well as evaluating long-term safety of somapacitan in a basket study design in children with ... | ||||||||||||||||||||||||||||
Medical condition: Short stature born small for gestational age Turner syndrome Noonan syndrome Idiopathic short stature | ||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||
Population Age: Children, Under 18 | Gender: Male, Female | |||||||||||||||||||||||||||
Trial protocol: IT (Ongoing) SI (Ongoing) IE (Ongoing) DE (Ongoing) FI (Ongoing) GR (Ongoing) NL (Ongoing) BE (Ongoing) AT (Ongoing) ES (Ongoing) PT (Ongoing) BG (Ongoing) PL (Ongoing) LV (Ongoing) HR (Ongoing) LT (Ongoing) | ||||||||||||||||||||||||||||
Trial results: (No results available) |
EudraCT Number: 2006-003699-36 | Sponsor Protocol Number: 20050154 | Start Date*: 2006-11-27 | |||||||||||
Sponsor Name:Amgen Inc. | |||||||||||||
Full Title: A Phase 2, Randomized, Double Blind, Placebo- Controlled Dose and Schedule Finding Trial to Evaluate the Safety and Efficacy of AMG 531 for Treatment of Chemotherapy- Induced Thrombocytopenia in Su... | |||||||||||||
Medical condition: Secondary prophylaxis for the treatment of chemotherapy induced thrombocytopenia (CIT) in subjects with Non-Small Cell Lung Cancer (NSCLC) receiving myelosuppressive chemotherapy. | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: IE (Completed) PT (Completed) AT (Prematurely Ended) HU (Completed) DE (Completed) IT (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2014-004685-25 | Sponsor Protocol Number: GO29665 | Start Date*: 2016-10-07 | |||||||||||
Sponsor Name:F. Hoffmann-La Roche Ltd | |||||||||||||
Full Title: A PHASE I/II, MULTICENTER, OPEN-LABEL, DOSE-ESCALATION STUDY OF THE SAFETY AND PHARMACOKINETICS OF COBIMETINIB IN PEDIATRIC AND YOUNG ADULT PATIENTS WITH PREVIOUSLY TREATED SOLID TUMORS | |||||||||||||
Medical condition: Solid Tumors | |||||||||||||
|
|||||||||||||
Population Age: Children, Adolescents, Under 18, Adults | Gender: Male, Female | ||||||||||||
Trial protocol: NL (Completed) IE (Completed) DK (Completed) GB (GB - no longer in EU/EEA) DE (Completed) ES (Completed) IT (Completed) FR (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2020-003517-35 | Sponsor Protocol Number: BHV3000-311 | Start Date*: 2021-05-05 | |||||||||||||||||||||||||||||||
Sponsor Name:Pfizer, Inc. | |||||||||||||||||||||||||||||||||
Full Title: Phase 3, multicenter, randomized, double-blind, group sequential, placebo-controlled study to assess efficacy and safety of rimegepant for the treatment of migraine (with or without aura) in childr... | |||||||||||||||||||||||||||||||||
Medical condition: Acute Migraine (with or without aura) | |||||||||||||||||||||||||||||||||
|
|||||||||||||||||||||||||||||||||
Population Age: Children, Adolescents, Under 18 | Gender: Male, Female | ||||||||||||||||||||||||||||||||
Trial protocol: SE (Ongoing) PL (Ongoing) ES (Ongoing) | |||||||||||||||||||||||||||||||||
Trial results: (No results available) |
Subscribe to this Search
To subscribe to the RSS feed for this search click here . This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here . This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
Download Options: | |
---|---|
Number of Trials to download: | |
Download Content: | |
Download Format: | |
Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. |
Query did not match any studies.